which drug reduces weight
Tirzepatide Vs Semaglutide - 5 Surprising Eye Risks
Tirzepatide and semaglutide each carry a modest but measurable eye risk, with roughly 2% of users developing nonarteritic anterior ischemic optic neuropathy, while semaglutide shows a 12% lower chance of new diabetic retinopathy compared with historical controls. Medical Disclaimer: This article is for informational purposes only and does not constitute